Silverback Therapeutics Inc. (SBTX) Social Stream



Silverback Therapeutics Inc. (SBTX): $5.87

0.06 (+1.03%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add SBTX to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#175 of 385

in industry

SILVERBACK THERAPEUTICS INC (SBTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering SILVERBACK THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-16 3 $54 $42 $49.333 $6.14 703.47%
2021-11-11 3 $52 $32 $42 $6.14 584.04%
2021-11-12 3 $52 $25 $36.333 $6.14 491.74%
2022-04-01 3 $6 $1.8 $3.9 $6.14 -36.48%
2022-04-04 1 $3.5 $3.5 $3.5 $6.14 -43%
2022-05-13 4 $5 $1.8 $3.433 $6.14 -44.09%

Price Target Last Issued April 4, 2022

The Trend in the Analyst Price Target


SBTX's average price target has moved up $0.35 over the prior 42 days.

Over the past 26 weeks, SBTX's average upside potential has been 71.36%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-12 3 52.0 25.0 36.333 8.45 329.98%
2022-04-04 4 3.5 3.5 3.500 3.24 8.02%
2022-04-04 1 6.0 1.8 3.766 3.24 16.23%
2022-04-04 4 6.0 1.8 3.766 3.24 16.23%
2022-05-13 3 5.0 1.8 3.433 2.96 15.98%

SBTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 3 0 0 3

The Trend in the Broker Recommendations


SBTX's average broker recommendation rating worsened by 1.4 over the prior 30 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • SILVERBACK THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 284.61% of all US stocks.
  • SBTX has a higher average analyst price target than 285.65% of stocks in the small market cap category.
  • SILVERBACK THERAPEUTICS INC's number of analysts covering the stock is greater than 123.12% of Healthcare stocks.
  • In terms of how SILVERBACK THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -356.46% of that group.

Stocks similar to SILVERBACK THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LABP, SNSE, and PHVS.

Is SBTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!